Surgical Innovations Group plc
SUN.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.04 | -0.35 | 0.55 |
| FCF Yield | -7.97% | -5.15% | -3.97% | -4.95% |
| EV / EBITDA | -62.38 | 37.56 | 23.71 | 85.64 |
| Quality | ||||
| ROIC | -7.54% | -3.38% | -1.43% | -2.75% |
| Gross Margin | 28.77% | 28.70% | 34.59% | 34.31% |
| Cash Conversion Ratio | 0.04 | -0.79 | 1.84 | 0.95 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.75% | 9.60% | 21.46% | -5.26% |
| Free Cash Flow Growth | -42.01% | 51.35% | 45.69% | -222.89% |
| Safety | ||||
| Net Debt / EBITDA | -10.56 | 2.80 | -0.06 | -3.47 |
| Interest Coverage | -7.99 | -4.52 | 0.42 | -3.69 |
| Efficiency | ||||
| Inventory Turnover | 2.87 | 3.00 | 2.35 | 2.02 |
| Cash Conversion Cycle | 135.73 | 120.23 | 85.71 | 114.16 |